Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-829-0 | CAS number: 57583-35-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- migrated information: read-across based on grouping of substances (category approach)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Preferred study for this SIDS endpoint. Methodology was similar to OECD Guideline 414; however, study was conducted using less than the recommended number of animals per dose group.
Data source
Reference
- Reference Type:
- publication
- Title:
- Maternal and fetal toxicity of dimethyltin in rats.
- Author:
- Noda, T.
- Year:
- 2 001
- Bibliographic source:
- Journal of Health Science. 47(6):544-551.
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 414 (Prenatal Developmental Toxicity Study)
- Deviations:
- not specified
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Dimethyltin dichloride
- EC Number:
- 212-039-2
- EC Name:
- Dimethyltin dichloride
- Cas Number:
- 753-73-1
- Molecular formula:
- C2H6Cl2Sn
- IUPAC Name:
- dimethyltin dichloride
- Reference substance name:
- Stannane, dichlorodimethyl-
- IUPAC Name:
- Stannane, dichlorodimethyl-
- Details on test material:
- - Name of test material (as cited in study report): Dimethyltin chloride
- Molecular formula (if other than submission substance): C2H6Cl2Sn
- Molecular weight (if other than submission substance): 219.67 g/mol
- Smiles notation (if other than submission substance): C[Sn](C)(CL)CL
- Analytical purity: >99.0%
- Stability under test conditions: stable
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: CLEA Japan, Inc.
- Age at study initiation: 3 months
- Weight at study initiation:
- Housing: individually housed
- Diet (e.g. ad libitum): NMF; ad libitum
- Water (e.g. ad libitum): ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 23 +/- 2 deg C
- Humidity (%): 60 +/-20%
- Photoperiod (hrs dark / hrs light): 12 hour light / 12 hour dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Saline
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: test substance dissolved in saline
VEHICLE
- Justification for use and choice of vehicle (if other than water): solubility
- Amount of vehicle (if gavage): 2 mL/kg - Analytical verification of doses or concentrations:
- not specified
- Details on analytical verification of doses or concentrations:
- no data
- Details on mating procedure:
- - Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: 1:1
- Length of cohabitation: overnight
- Verification of same strain and source of both sexes: yes
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy
- Any other deviations from standard protocol: less than the recommended number of animals per dose. - Duration of treatment / exposure:
- days 7 - 17 of gestation- first study
days 7-9, 10-12, 13-15, or 16-17; on two or three consecutive days- second study - Frequency of treatment:
- daily
- Duration of test:
- 20 days
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
5, 10, 15, and 20 mg/kg/day
Basis:
nominal conc.
- Remarks:
- Doses / Concentrations:
20 and 40 mg/kg/day
Basis:
nominal conc.
- No. of animals per sex per dose:
- mated females were assigned to five groups of 10 rats each- first study
mated females were assigned to eight groups of 8-11 rats each- second study - Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: In the second study, higher doses were selected, at shorter periods of gestation, in order to reduce maternal toxicity
- Rationale for animal assignment (if not random): random
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: daily
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: daily
BODY WEIGHT: Yes
- Time schedule for examinations: daily
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: No data
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: No data
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
POST-MORTEM EXAMINATIONS: Yes
- Sacrifice on gestation day # 20
- Organs examined: Maternal thymus and brain weights
- Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes
Examinations included:
- Gravid uterus weight: Yes - in the second teratology study only
- Number of corpora lutea: Yes
- Number of implantations: Yes
- Number of early resorptions: Yes - total resorptins
- Number of late resorptions: Yes - total resorptions - Fetal examinations:
- - External examinations: Yes: all per litter
- Visceral examinations: Yes: half per litter
- Skeletal examinations: Yes: half per litter
- Head examinations: No data - Statistics:
- Fisher's exact test was used to analyze data on the number of dams with living fetuses, number of dams with total resorptions, and the number of malformed fetuses. Other data were analyzed using Dunnett's (1964) multiple comparison method in a parametric or non-parametric manner. The litter was used as the statistical unit for calculation of fetal values.
- Indices:
- no data
- Historical control data:
- no data
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yes
Details on maternal toxic effects:
First teratology study: There was a dose-dependent reduction of maternal body weight gain of pregnant rats treated orally with the test substance during days 7-17 of gestation. Maternal body weight gain was significantly reduced in pregnant rats treated with 15 or 20 mg/kg/day of the test substance. Maternal food intake was also significantly reduced in animals treated with 20 mg/kg/day. Changes in food intake were not significantly different in pregnant rats in the remaining dose groups. Two animals receiving the test substance at 20 mg/kg/day died, one on day 18 of gestation and the other on day 19 of gestation. These animals exhibited clinical signs of toxicity, including piloerection, ataxia, perinasal and periocular staining, vaginal bleeding, tremor, and convulsion for about four days prior to death. No gross pathological changes in the organs of the dead dams were noted at necropsy. No other mortalities were observed in either the control or test substance-treated groups. During the late treatment period, all animals at 20 mg/kg/day showed clinical signs of toxicity, including perinasal and periocular staining, piloerection, and ataxia. Vaginal bleeding, tremor, and convulsion were also observed in three pregnant animals from this group. No clinical signs of toxicity were observed in the other treated groups. There was a dose-dependent reduction in maternal thymus weights, with a significant reduction at 15 and 20 mg/kg/day on day 20 of gestation. Maternal brain weight was not affected in any treated group. Total resorption was observed in one of the eight living pregnant rats at 20 mg/kg/day on day 20 of gestation. There was no significant difference in the number of corpora lutea, number of implants, number of living fetuses, or the incidence of post-implantation loss and sex ratio.
Second teratology study: Significant reductions in maternal body weight gain on days 13, 16, and 17 of gestation and food intake on the consecutive days of gestation after day 12, were reported for pregnant rats exposed at 40 mg/kg/day on days 10-12 of gestation. Maternal body weight gain was not significantly reduced in the other treated groups. General behavior among groups, including the control group, was not significantly different. Maternal thymus weights and adjusted body weight gain in pregnant rats exposed to 20 mg/kg/day on days 10-12 and in every treatment group at 40 mg/kg/day were significantly reduced. Gravid uterus and maternal body weights were not affected in either the 20 or 40 mg/kg/day groups. Total resorption was observed in one of 10 dams exposed to 40 mg/kg/day during days 7-9 of gestation. No significant differences were reported in the number of corpora lutea, implants, or living fetus. The incidence of post-implantation loss, the sex ratio were not significant in any treatment group. At 40 mg/kg/day, maternal body weight gain and maternal thymus weights were significantly reduced. Maternal thymus weights and adjusted body weight gain were also significantly reduced at 20 mg/kg/day on days 10-12 of gestation.
Effect levels (maternal animals)
- Dose descriptor:
- NOAEL
- Effect level:
- 10 mg/kg bw/day
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes
Details on embryotoxic / teratogenic effects:
First teratology study: There was a dose-dependent reduction in mean body weight of living fetuses (both sexes), with significant reduction at 15 and 20 mg/kg/day. The incidence of external malformations increased in fetuses from dams exposed at 20 mg/kg/day during days 7-17 of gestation. There was a statistically significant increase in the number of fetuses with dilation of the renal pelvis from dams exposed to DMTC at 20 mg/kg/day during days 7-17 of gestation. Cleft palate was observed in 21 fetuses from five of seven pregnant rats with living fetuses on day 20 of gestation. In addition to cleft palate, one fetus was associated with general edema and pes varus, and one with general edema. Omphalocele was observed in two fetuses from one dam exposed to 15 mg/kg/day; however, the incidence was not statistically significant. No other external malformations were observed in either the control or treated groups. No other visceral malformations observed were statistically significant. No statistically significant difference in the incidence of skeletal malformations and skeletal variations were observed in either the control or treated groups.
Second teratology study: Mean fetal body weight was reduced in females from dams exposed to 40 mg/kg/day during days 7-9. The incidence of male fetal body weight was not significant in any treatment group. There was no significant increase in the incidence of external, skeletal, or visceral malformations at either 20 or 40 mg/kg/day. Cleft palate was not observed in fetuses from dams exposed at 20 or 40 mg/kg/day on days 7-9, 10-12, 13-15, or 16-17 of gestation. The numbers of fetuses with skeletal variations, cervical ribs, and/or splitting of the first cervical vertebral arch increased significantly in the groups treated at 40 mg/kg/day on days 7-9 and/or days 13-15 of gestation. Fetuses with kinked ureter significantly increased in the group treated at 40 mg/kg/day on days 16-17 of gestation.
Effect levels (fetuses)
- Dose descriptor:
- NOAEL
- Effect level:
- 10 mg/kg bw/day
- Basis for effect level:
- other: fetotoxicity
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- The findings of the first teratology study suggest that dimethyltin dichloride was not teratogenic, but was toxic to dams and fetuses at 15 mg/kg/day. In the second teratology study, a no-observed-adverse-effect-level (NOAEL) for dams could not be established. Adverse effects to dams were reported at both 20 and 40 mg/kg/day on days 10-12 of gestation.
The authors reported that under the conditions of the first teratological study, the NOAEL for maternal and fetal toxicity was considered to be 10 mg/kg/day. - Executive summary:
The maternal and fetal toxicity of dimethyltin dichloride was examined in two teratological studies in pregnant Wistar rats. In one study, the animals were treated by oral gavage with the test substance at doses of 0, 5, 10, 15 or 20 mg/kg/day on gestational days 7 -17. In the second study, animals were treated by oral gavage at doses of 0, 20 or 40 mg/kg/day on two or three consecutive days at one of four different periods of gestation (gestational days 7 -9, 10 -12, 13 -15, or 16 -17). Caesarean sections were performed in day 20 of gestation in both studies. In the first study, vaginal bleeding, tremor and convulsions were observed in animals treated at 20 mg/kg/day after day 15 of gestation. Of ten dams treated with 20 mg/kg/day, two died and one exhibited total resorption. While an increase in the incidence of cleft palate was found in fetuses of animals treated with 20 mg/kg/day, the dams so treated exhibited severe clinical signs of toxicity. Animals treated in the second study with doses of 20 or 40 mg/kg/day at one of four periods of gestation had a reduction in the adjusted body weight gain but not in gravid uterus weight and did not show any evidence of teratogenic effects at either dose and period tested. These studies suggest that the test substance did not produce teratogenic effects at dose levels where no maternal toxicity was observed. It was suggested that under the conditions of the first study, since no signs of maternal or fetal toxicity could be detected up to 10 mg/kg/day, this dose was chosen to represent the no-observed-adverse-effect-level (NOAEL).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.